Relapsing-remitting multiple sclerosis and Hyperreflexia

Summary:

Hyperreflexia is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Hyperreflexia with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 91 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Hyperreflexia?

Hyperreflexia (overactive or over responsive reflexes) is found to be associated with 422 drugs and 651 conditions by eHealthMe. Check the latest studies of Hyperreflexia.



On Aug, 04, 2026

91 people who have Relapsing-Remitting Multiple Sclerosis and Hyperreflexia are studied.

Would you have Hyperreflexia when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Hyperreflexia *:

  • female: 81.4 %
  • male: 18.6 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Hyperreflexia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.54 %
  • 20-29: 10.77 %
  • 30-39: 16.92 %
  • 40-49: 44.62 %
  • 50-59: 23.08 %
  • 60+: 3.08 %

Common co-existing conditions for these people *:

  1. Gait Disturbance: 11 people, 12.09%
  2. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 8 people, 8.79%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 7.69%
  4. High Blood Pressure: 7 people, 7.69%
  5. Dyslipidaemia (abnormal amount of lipids): 4 people, 4.40%
  6. Weakness: 2 people, 2.20%
  7. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 2 people, 2.20%
  8. Muscle Spasms (muscle contraction): 2 people, 2.20%
  9. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 2.20%
  10. Balance Disorder: 1 person, 1.10%

Common drugs taken by these people *:

  1. Gilenya: 55 people, 60.44%
  2. Ampyra: 9 people, 9.89%
  3. Vitamin D: 9 people, 9.89%
  4. Avonex: 7 people, 7.69%
  5. Movicol: 6 people, 6.59%
  6. Rebif: 5 people, 5.49%
  7. Solu-Medrol: 5 people, 5.49%
  8. Clexane: 5 people, 5.49%
  9. Ocrevus: 5 people, 5.49%
  10. Keppra: 5 people, 5.49%

Common symptoms for these people *:

  1. Hypoaesthesia (reduced sense of touch or sensation): 46 people, 50.55%
  2. Movement - Uncoordinated: 39 people, 42.86%
  3. Gait Disturbance: 36 people, 39.56%
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 36 people, 39.56%
  5. Weakness: 36 people, 39.56%
  6. Tremor (trembling or shaking movements in one or more parts of your body): 33 people, 36.26%
  7. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 30 people, 32.97%
  8. Fatigue (feeling of tiredness): 27 people, 29.67%
  9. Sensory Disturbance (sense disturbance): 25 people, 27.47%
  10. Dizziness: 24 people, 26.37%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperreflexia?

- Check whether Hyperreflexia is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hyperreflexia:

All the conditions that are associated with Hyperreflexia:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperreflexia and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: